Publications by authors named "Changling Tu"

Claim this Profile
T
TBX5-AS1 induces ER stress and suppresses lung cancer growth and tumor stemness via the miR-494-3p/ATF6 axis.
Guoqin Wang, Chaojiang Fu, Changling Tu, Zhuangqing Yang, Wei Shi

Cell Stress Chaperones· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative changing patterns of systemic immune-inflammatory index (SII) and outcomes in stage I-III non-small cell lung cancer: a retrospective cohort study.
Yanling Miao, Chunxia Li, Yongrui Zhang, Zhenhui Li, Yanli Li, Changling Tu

J Thorac Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a computed tomography-based immune ecosystem diversity index as an imaging biomarker in non-small cell lung cancer.
Lan He, Zhen-Hui Li, Li-Xu Yan, Xin Chen, Sebastian Sanduleanu, Chang-Ling Tu

Eur Radiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and reliability and validity test of the Fear of Cancer Scale (FOCS).
Lin-Sen Feng, Xiao-Qian Wu, Qing-Li Li, Qing Yang, Fu-Lin Yin, Chang-Ling Tu

Ann Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
Kun Wang, Jian He, Changling Tu, Hui Xu, Xugang Zhang

BMC Mol Cell Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Microenvironment: New Insight for Familial Adenomatous Polyposis.
Jun Yang, Zhengqi Wen, Wenliang Li, Xianghua Sun, Junrui Ma, Changling Tu

Front Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination Therapy of Fluorouracil and Oxaliplatin Suppress the Progression of Colon Cancer Through miR-183-5p/SOCS3 Axis and Downregulating PD-L1.
Changling Tu, Yufeng Wang, Xianshuo Cheng, Ying Zhu, Wenli Yuan

Cancer Manag Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of the cancer symptoms discrimination scale: a cross-sectional survey of students in Yunnan, China.
Lin-Sen Feng, Zheng-Jiao Dong, Ruo-Yu Yan, Chang-Ling Tu, Lan-Yu Zhang

BMC Palliat Care· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Postoperative Peripheral CD4+ T Cells Percentage in Stage I-III Colorectal Cancer: A Retrospective Multicenter Cohort Study of 1028 Subjects.
Zhenhui Li, Shaoyou Li, Yun Liang, Hongjiang Pu, Changling Tu

Cancer Manag Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer.
Wenli Yuan, Deyao Deng, Hongchao Jiang, Changling Tu, Xueqin Shang

Cancer Immunol Immunother· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale - parent form.
Susan Shur-Fen Gau, Chi-Yung Shang, Shih-Kai Liu, Chien-Ho Lin, James M Swanson, Chang-Ling Tu

Int J Methods Psychiatr Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis